A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and autophagy in early-stage Huntington’s disease patients. Groundbreaking research i...
A 12-week clinical trial at the University of Florida investigates time-restricted eating in early-stage Huntington’s disease, with potential benefits for mitochondrial function and cognitive pe...
A 12-week TRE protocol (6h window) is being tested for early Huntington’s Disease, showing potential benefits for mitochondrial function and autophagy with 80% adherence expected. New clinical t...
Emerging research suggests time-restricted feeding may improve symptoms and slow neurodegeneration in Huntington’s disease through circadian rhythm synchronization and enhanced autophagy. New cl...
Recent research reveals how intermittent fasting protocols interact with circadian rhythms to improve insulin sensitivity, gut microbiome diversity, and metabolic markers beyond weight loss. Emerging ...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
A recent PLoS One study reveals that a 12-week time-restricted eating protocol improves mitochondrial function and reduces polyQ aggregation in Huntington’s disease patients. Groundbreaking rese...
Emerging research reveals how fasting and timed eating may enhance brain cell function and slow neurodegenerative disease progression through autophagy and mitochondrial efficiency. New studies demons...
Exploring the science behind intermittent fasting, its effects on weight loss, insulin sensitivity, and recent research on its benefits for prediabetes and hypertension management. Recent studies high...
New research suggests time-restricted eating may improve mitochondrial function and reduce protein aggregates in early-stage Huntington’s disease patients. Emerging evidence indicates TRE may offer ...
